Unaudited Consolidated Balance Sheets - USD ($) $ in Millions	Mar. 31, 2022		Dec. 31, 2021
Current Assets
Cash and cash equivalents	$ 605		$ 536
Trade receivables - third party and affiliates	1,390		1,161
Non-trade receivables, net	523		506
Inventories	1,549		1,524
Marketable securities	9		10
Other assets	124		70
Total current assets	4,200		3,807
Investments in affiliates	847		823
Property, plant and equipment (net of accumulated depreciation - 2022: $3,538; 2021: $3,484)	4,188		4,193
Operating Lease, Right-of-Use Asset	267		236
Deferred income taxes	244		248
Other assets	569		521
Goodwill	1,396	[1]	1,412
Intangible assets, net	715		735
Total assets	12,426		11,975
Current Liabilities
Short-term borrowings and current installments of long-term debt - third party and affiliates	860		791
Trade payables - third party and affiliates	1,169		1,160
Other liabilities	419		473
Income taxes payable	106		81
Total current liabilities	2,554		2,505
Long-term debt, net of unamortized deferred financing costs	3,132		3,176
Deferred income taxes	563		555
Uncertain tax positions	296		280
Benefit obligations	543		558
Operating lease liabilities	223		200
Other liabilities	162		164
Commitments and Contingencies
Stockholders' Equity
Preferred stock, $0.01 par value, 100,000,000 shares authorized (2022 and 2021: 0 issued and outstanding)	0		0
Common stock, $0.0001 par value, 400,000,000 shares authorized (2022: 170,043,630 issued and 108,307,341 outstanding; 2021: 169,760,024 issued and 108,023,735 outstanding)	0		0
Treasury stock, at cost (2022: 61,736,289 shares; 2021: 61,736,289 shares)	(5,492)		(5,492)
Additional paid-in capital	326		333
Retained earnings	10,106		9,677
Accumulated other comprehensive income (loss), net	(333)		(329)
Total Celanese Corporation stockholders' equity	4,607		4,189
Noncontrolling interests	346		348
Total equity	4,953		4,537
Total liabilities and equity	$ 12,426		$ 11,975

[1] There were no accumulated impairment losses as of March 31, 2022.